Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium

Cited by (164)

Items 101–164 of 164

1. Mutationally-activated PI3’-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase
   J. Edward van Veen, Michael T. Scherzer, Julia Boshuizen, Mollee Chu, Annie Liu, Allison S. Landman, Shon Green, Christy L. Trejo, Martin McMahon · 2019 · eLife
2. Wnt signaling and tumors (Review)
   Huaishi Wang, Lihai Zhang, Chao Hu, Hui Li, Mingyan Jiang · 2024 · Molecular and Clinical Oncology
3. Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A–β-Catenin Signaling and Restricts Tumor Growth and Metastasis
   Shrankhla Maheshwari, Srinivasa Rao Avula, Akhilesh Singh, Lakhwinder Singh, Gopala Reddy Palnati, Rakesh Kumar Arya, Hanumanth Srikanth Cheruvu, Sudhir Shahi, Tanuj Sharma, Sanjeev Meena et al. · 2017 · Molecular Cancer Therapeutics
4. NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer
   Rui Bai, Cheng Yuan, Wenjie Sun, Jian‐Guo Zhang, Yuan Luo, Yanping Gao, Yangyi Li, Yan Qing Gong, Conghua Xie · 2021 · International Journal of Biological Sciences · Retracted
5. TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer
   Aina Martín-Medina, Noemi Cerón-Pisa, Esther Martinez-Font, Hanaa Shafiek, Antònia Obrador‐Hevia, Jaume Sauleda, Amanda Iglesias · 2022 · International Journal of Molecular Sciences
6. GMI, a fungal immunomodulatory protein from Ganoderma microsporum, induce apoptosis via β‐catenin suppression in lung cancer cells
   I‐Lun Hsin, Jen-Chieh Hsu, Wenjun Wu, Hsueh‐Ju Lu, Ming‐Fang Wu, Jiunn‐Liang Ko · 2018 · Environmental Toxicology
7. The Expressions of Wnt/β-catenin Pathway-Related Components in Brainstem Gliomas
   Wenhao Wu, Yongji Tian, Hong Wan, Yongmei Song, Junhua Li, Liwei Zhang · 2013 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
8. Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) rs10845498 Polymorphism Is Associated with a Decreased Risk of Non-Small Cell Lung Cancer
   Dehou Deng, Yongjun Zhang, Wenglong Bao, Xiangming Kong · 2014 · International Journal of Medical Sciences
9. Secreted Wnt6 mediates diabetes-associated centrosome amplification via its receptor FZD4
   Qin Ju He, Pu Wang, Qin Qin Liu, Qi Gui Wu, Yuan Fei Li, Jie Wang, Shao Chin Lee · 2019 · American Journal of Physiology-Cell Physiology
10. WISP1 silencing confers protection against epithelial–mesenchymal transition of renal tubular epithelial cells in rats via inactivation of the wnt/β‐catenin signaling pathway in uremia
    Yuan‐Zhen Chen, Dan‐Qin Sun, Yi Zheng, Guang‐Kuai Zheng, Rongquan Chen, Lin Mei, Lianfang Huang, Cong Huang, Dan Song, Benqing Wu · 2018 · Journal of Cellular Physiology
11. Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice
    Inuk Zandvakili, Ashley Kuenzi Davis, Guodong Hu, Yi Zheng · 2015 · PLoS ONE
12. WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer
    Kee‐Beom Kim, Dong-Wook Kim, Youngchul Kim, Jun Tang, Nicole Kirk, Yongyu Gan, Bong-Jun Kim, Bingliang Fang, Jae‐Il Park, Yi Zheng et al. · 2022 · Cancer Research
13. Intracellular signals of lung cancer cells as possible therapeutic targets
    Kiyomichi Tanaka, Keiki Kumano, Hiroo Ueno · 2015 · Cancer Science
14. Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma
    J. Cho, Sun Young Kim, Y. J. Kim, Min-Seob Sim, S.T. Kim, N. K. D. Kim, Kihyun Kım, Woong‐Yang Park, J. H. Kim, Kee‐Taek Jang et al. · 2017 · Clinical & Translational Oncology
15. Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studies
    Mona Maharjan, Raihanul Bari Tanvir, Kamal Chowdhury, Wenrui Duan, Ananda Mohan Mondal · 2020 · BMC Bioinformatics
16. Uterine organoids reveal insights into epithelial specification and plasticity in development and disease
    Jason A. Rizo, Vakil Ahmad, Jacob M. Pru, Sarayut Winuthayanon, Sridevi Challa, Tae Hoon Kim, Jae‐Wook Jeong, Thomas E. Spencer, Andrew M. Kelleher · 2025 · Proceedings of the National Academy of Sciences
17. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas
    Ester Sànchez‐Tilló, Leire Pedrosa, Ingrid Vila, Yongxu Chen, Balázs Győrffy, Lidia Sánchez-Moral, Laura Siles, Juan José Lozano, Anna Esteve‐Codina, Douglas S. Darling et al. · 2023 · JCI Insight
18. The Inhibition of Wnt Restrain KRASG12V-Driven Metastasis in Non-Small-Cell Lung Cancer
    Pei-Shan Hung, Ming-Hung Huang, Yuan‐Yeh Kuo, James Chih‐Hsin Yang · 2020 · Cancers
19. Blastocyst complementation reveals that NKX2‐1 establishes the proximal‐peripheral boundary of the airway epithelium
    Enhong Li, Vladimir Ustiyan, Bingqiang Wen, Gregory T. Kalin, Jeffrey A. Whitsett, Tanya V. Kalin, Vladimir V. Kalinichenko · 2021 · Developmental Dynamics
20. CircRNAs and miRNAs: Key Player Duo in Breast Cancer Dynamics and Biomarkers for Breast Cancer Early Detection and Prevention
    Nour Maatouk, Abdallah Kurdi, Sarah Marei, Rihab Nasr, Rabih Talhouk · 2024 · International Journal of Molecular Sciences
21. Hopping between Differentiation States in Lung Adenocarcinoma
    Hideo Watanabe, Matthew M. Meyerson · 2013 · Cancer Cell
22. Re: The Wnt Signaling Pathway in Non-Small Cell Lung Cancer
    Roland Hubaux, Kelsie L. Thu, Wan L. Lam · 2014 · JNCI Journal of the National Cancer Institute
23. Iloprost requires the Frizzled-9 receptor to prevent lung cancer
    Kayla M. Sompel, Lori D. Dwyer‐Nield, Alex J. Smith, Alamelu P. Elango, Donald S. Backos, Bicheng Zhang, James Gross, Kristina Ternyak, Jennifer L. Matsuda, Katrina W. Kopf et al. · 2022 · iScience
24. Leucine zipper transcription factor-like 1 binds adaptor protein complex-1 and 2 and participates in trafficking of transferrin receptor 1
    Kanyarat Promchan, Ven Natarajan · 2020 · PLoS ONE
25. Heterogeneity and targeted therapy-induced adaptations in lung cancer revealed by longitudinal single-cell RNA sequencing
    Ashley Maynard, Caroline Elizabeth McCoach, Julia K. Rotow, Lincoln Harris, Franziska Haderk, Daniel Lucas Kerr, Elizabeth A. Yu, Erin Lynn Schenk, Weilun Tan, Alexander Zee et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
26. The NcRNA/Wnt axis in lung cancer: oncogenic mechanisms, remarkable indicators and therapeutic targets
    Zhong Yang, Jiawei He, Chunxia Huang, Heng-Zhou Lai, Xueke Li, Chuan Zheng, Xi Fu, Fengming You, Qiong Ma · 2025 · Journal of Translational Medicine
27. Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell Lines
    Renato José da Silva Oliveira, Izabela Natália Faria Gomes, Luciane Sussuchi da Silva, André van Helvoort Lengert, Ana Carolina Laus, Matias Eliseo Melendez, Carla Carolina Munari, Fernanda de Paula Cury, Giovanna Barbarini Longato, Rui Manuel Reis · 2022 · International Journal of Molecular Sciences
28. Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
    İsa Taş, Ruben Jacobs, Juliane Albrecht, Sebastián A. Barrientos, J. Aberg, Wondossen Sime, Hans Brunnström, Helena Persson, Julhash Uddin Kazi, Ramin Massoumi · 2025 · Journal of Experimental & Clinical Cancer Research
29. TNFRSF19 within the 13q12.12 Risk Locus Functions as a Lung Cancer Suppressor by Binding Wnt3a to Inhibit Wnt/β-Catenin Signaling
    Xianglin Zuo, Xuchun Wang, Tingzheng Ma, Shuhan Chen, Pingping Cao, He Cheng, Nan Yang, Xiao Han, Wei Gao, Xiaoyu Liu et al. · 2023 · Molecular Cancer Research
30. β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells
    Previn Dutt, Nasir Haider, Samar Mouaaz, Lauren Podmore, Vuk Stambolic · 2024 · Proceedings of the National Academy of Sciences
31. Resveratrol Effects on Molecular Pathways and MicroRNAs in Gastrointestinal Cancers
    Amirhossein Davoodvandi, Pouya Mahdavi Sharif, Parisa Maleki Dana, Zatollah Asemi · 2022 · Current Medicinal Chemistry
32. Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study.
    Ying Wang, Weiyu Jiang, Xiaogu Liu, Yongjun Zhang · 2015 · PubMed Central
33. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells
    Yann Duchartre, Yong‐Mi Kim, Michaël Kahn · 2017 · Methods in molecular biology
34. Tankyrase 2 (TNKS2) polymorphism associated with risk in developing non-small cell lung cancer in a Chinese population
    Ying Wang, Weiyu Jiang, Xiaogu Liu, Yongjun Zhang · 2015 · Pathology - Research and Practice
35. KCTD10 inhibits lung cancer metastasis and angiogenesis via ubiquitin-mediated β-catenin degradation
    Zihao Yin, Shengwen Long, Hao Zhou, Mi Ouyang, Qinghao Wang, Jun He, Rongyu Su, Zhiwei Li, Xiaofeng Ding, Shuanglin Xiang · 2025 · Frontiers in Immunology
36. Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas
    Melanie H. Kucherlapati · 2022 · Cell Cycle
37. SMEK1 promotes lung adenocarcinoma proliferation and invasion by activating Wnt/β-catenin signaling pathway
    Dandan Chen, Shang Gao, Fei Gao, Ai Liu, Jiangxia Li, Qiji Liu, Qiji Liu · 2022 · Clinical & Translational Oncology
38. EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS G12D tumor development and propagation
    Ariel Pribluda, Anneleen Daemen, Anthony Lima, Xi Wang, Marc A. Hafner, Chungkee Poon, Zora D. Modrusan, Anand Kumar Katakam, Oded Foreman, Jefferey Eastham et al. · 2022 · eLife
39. An organoid CRISPRi screen revealed that SOX9 primes human fetal lung tip progenitors to receive WNT and RTK signals
    Dawei Sun, Oriol Llorà-Batlle, Jelle van den Ameele, John Christopher Thomas, Peng He, Kyungtae Lim, Walfred W. C. Tang, Chu‐Fan Xu, Kerstin B. Meyer, Sarah Amalia Teichmann et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
40. Dishevelled Segment Polarity Protein 3: A Novel Prognosis-related Marker in Pan-driver-gene-negative Lung Adenocarcinoma
    Yongmei Cui, Cuilan Tang, Jinrui Guo, Yu Sun, Zunfu Ke · 2023 · Journal of Cancer
41. Protocol for generation of mouse and human endometrial assembloids
    Vakil Ahmad, Jason A. Rizo, Hong Im Kim, Abdallah W. Abdelhady, Chaman Ranjit, Thomas E. Spencer, Andrew M. Kelleher · 2026 · Biology of Reproduction
42. Pulmonary Epithelium Cell Fate Determination: Chronic Obstructive Pulmonary Disease, Lung Cancer, or Both
    Yu Xu, Mengxia Li, Li Bai · 2024 · American Journal of Respiratory Cell and Molecular Biology
43. Balancing the developmental niches within the lung
    Edward E. Morrisey · 2013 · Proceedings of the National Academy of Sciences
44. Impact of Baseline β-Catenin Comutations on Prognosis in EGFR-Mutant Lung Cancer
    Jonas Kulhavy, Katja Maurus, Miriam Blasi, Stephanie Brändlein, Simone Reu‐Hofer, Julia Doll, Julia Böck, Albrecht Stenzinger, Daniel N. Kazdal, Jan Budczies et al. · 2025 · JCO Precision Oncology
45. Stem cell reprogramming as a driver of basal cell carcinoma
    David Wei‐Min Tan, Nick Barker · 2012 · Nature Cell Biology
46. Role of WNT1-inducible-signaling pathway protein 1 in etoposide resistance in lung adenocarcinoma A549 cells.
    Yunhua Xu, Shun Lü · 2015 · PubMed
47. The lung cancer stem cell niche
    Ivan Bertoncello · 2020 · Advances in stem cells and their niches
48. A Lung Cancer Mouse Model Database
    Ling Cai, Ying Gao, Ralph J. DeBerardinis, George K. Acquaah-Mensah, Vassilis Aidinis, Jennifer Beane, Shyam S. Biswal, Ting Chen, Carla P. Concepcion, Barbara M. Grüner et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
49. Translating clinical gene sequencing into a foundational representation of tumor subtype
    JungHo Kong, Ingoo Lee, Dean Boecher, Akshat Singhal, Marcus R. Kelly, Jimin Moon, Chang Ho Ahn, Chan‐Young Ock, Tannavee Kumar, Timothy J. Sears et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
50. Tankyrase: Function and Tankyrase Inhibitor in Cancer
    Mi Kyung Kim · 2018 · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters
51. WNT5A-RHOA axis is a new vulnerability in small-cell lung cancer
    Kee‐Beom Kim, Dong Wook Kim, Youngchul Kim, Jun Tang, Nicole Kirk, Yongyu Gan, Bingliang Fang, Jae‐Il Park, Yi Zheng, Kwon-Sik Park · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
52. lncRNA AFAP1-AS1 promotes colon cancer progression via the Wnt/β-catenin signaling pathway
    Yu Zeng, Jin Wang, Juqiang ZHANG, Feng PENG, Xiaosong GONG, Minghao WU, Hongliang YANG · 2022 · Minerva Biotechnology and Biomolecular Research
53. NEK10 tyrosine phosphorylates β-catenin to regulate its cytoplasmic turnover
    Previn Dutt, Nasir Haider, Samar Mouaaz, Lauren Podmore, Vuk Stambolic · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
54. Data from Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway
    Nathan Harmston, Jun Yi Stanley Lim, Oriol Arqués, Héctor G. Pálmer, Enrico G. Petretto, David M. Virshup, Babita Madan · 2023
55. Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer
    Kee‐Beom Kim, Dong-Wook Kim, Youngchul Kim, Jun Tang, Nicole Kirk, Yongyu Gan, Bong-Jun Kim, Bingliang Fang, Jae‐Il Park, Yi Zheng et al. · 2023
56. Dependence of NPPS creates a targetable vulnerability in RAS-mutant cancers
    Ruixue Xia, Peichen Zou, Jun-ting Xie, Ya‐Bin Tang, Miaomiao Gong, Fu Fan, Ayinazhaer Aihemaiti, Yuqing Liu, Ying H. Shen, Bin-bing S. Zhou et al. · 2024 · Acta Pharmacologica Sinica
57. Additional file 2 of Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studies
    Mona Maharjan, Tanvir, Raihanul Bari, Kamal Chowdhury, Duan, Wenrui, Ananda Mohan Mondal · 2020 · Figshare
58. Additional file 3 of Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studies
    Mona Maharjan, Tanvir, Raihanul Bari, Kamal Chowdhury, Duan, Wenrui, Ananda Mohan Mondal · 2020 · Figshare
59. Additional file 4 of Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studies
    Mona Maharjan, Tanvir, Raihanul Bari, Kamal Chowdhury, Duan, Wenrui, Ananda Mohan Mondal · 2020 · Figshare
60. Additional file 5 of Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studies
    Mona Maharjan, Tanvir, Raihanul Bari, Kamal Chowdhury, Duan, Wenrui, Ananda Mohan Mondal · 2020 · Figshare
61. Caractérisation fonctionnelle du complexe LKB1/STRADß au cil primaire et les conséquences au cours de la tumorigenèse
    Pauline Maurin · 2016 · theses.fr (ABES)
62. Inflammatory pathways in lung cancer development
    Bisma Jan, Shafia Bashir, Abida Yousuf, Roohi Mohi-ud-din, Reyaz Hassan Mir, Mubashir Hussain Masoodi · 2026 · Elsevier eBooks
63. Inhibition of IGF1R in Early MMTV-Wnt1 Mammary Tumors: A Transcriptomic Analysis
    Joseph J. Bulatowicz, Alexander D. Lemenze, Elvan Dogan, Christopher A Galifi, Krystopher Maingrette, Quan Shang, Teresa L. Wood · 2026 · Cancers
64. Mouse Models of RAS-Induced Tumors and Developmental Disorders
    Carmen E. Guerra, Mariano Barbacid · 2014 · Springer eBooks